Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
01 1Pharmathen SA
01 1PALIPERIDONE
01 1Greece
01 1Active
01 1Complete
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
GDUFA
DMF Review : Complete
Rev. Date : 2017-02-27
Pay. Date : 2016-12-01
DMF Number : 31062
Submission : 2016-12-27
Status : Active
Type : II
20
Pharmathen Sa, based in Greece, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
One of their notable products is PALIPERIDONE, with a corresponding US DMF Number 31062.
Remarkably, this DMF maintains an Active status since its submission on December 27, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 27, 2017, and payment made on December 01, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II
